BIG BIG NEWS: Anthropic just announced it's developing drugs of its own just after launching Claude Science, an AI workbench connected to 60+ scientific tools and databases, capable of running single-cell RNA sequencing and CRISPR design autonomously now they're not just building the tool. they're using it themselves to run an internal drug discovery lab targeting neglected diseases the traditional pharma industry has written off as not commercially attractive Anthropic's head of life sciences said it plainly: "there's no substitute for having our own experiences alongside you all in the trenches trying to develop drugs" this is on top of their $400M acquisition of Coefficient Bio in April, which quietly gave them the life sciences expertise to make this move Isomorphic Labs, Recursion, Insilico all entered this race with AI-first drug discovery now the frontier AI labs are not just tooling up pharma they are becoming pharma the acceleration of biology can never be doubted ever again